Evidence map›Paper›PMID 21791620›Full record

ReviewAmerican journal of physiology. Endocrinology and metabolism2011

Leptin in human physiology and pathophysiology.

Christos S Mantzoros, Faidon Magkos, Mary Brinkoetter, Elizabeth Sienkiewicz, Tina A Dardeno, Sang-Yong Kim, Ole-Petter R Hamnvik, Anastasia Koniaris

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Endocrinology and metabolism, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00130117 (Randomized, Double-blind, Placebo-controlled Trial of Human Recombinant Leptin), which is not on this map. Cited by 255 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
255citing papers in PubMed, 6 pooled it
20.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00130117 phase2completednot on this map

Randomized, Double-blind, Placebo-controlled Trial of Human Recombinant Leptin (r-metHuLeptin) for the Treatment of Hypothalamic (Exercise-Induced) Amenorrhea

TypeinterventionalSponsorBeth Israel Deaconess Medical CenterRan2010 to 2016Enrolled20ConditionsAmenorrheaArmsr-metHuLeptin, Oral Contraceptive Pills (OCPs), Placebo
3 · Its place in the literature

Who cites it

255 citing papers in PubMed, 6 syntheses or guidelines pooled it, 577 citations in OpenAlex.

  1. New Mediators in the Crosstalk between Different Adipose Tissues.International journal of molecular sciences · 2024
    Pooled it
  2. Sleep apnea and eye diseases: evidence of association and potential pathogenic mechanisms.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Does Visceral or Subcutaneous Fat Influence Peripheral Cortical Bone Strength During Adolescence? A Longitudinal Study.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018
    Trial
  11. Trial
  12. Trial
  13. Dose-dependent effects of atorvastatin on myocardial infarction.Drug design, development and therapy · 2015
    Trial
  14. Review
  15. Peptide Hormones in Appetite Regulation: A Complex Network.Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

195 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Christos S MantzorosDivision of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. cmantzor@bidmc.harvard.edu
Faidon Magkos
Mary Brinkoetter
Elizabeth Sienkiewicz
Tina A Dardeno
Sang-Yong Kim
Ole-Petter R Hamnvik
Anastasia Koniaris
Hadassah Medical Center · ILVA Boston Healthcare System · USChosun University · KRHarokopio University of Athens · GR

Funding

Role of Leptin in the Neuroendocrine Response to FastingR01DK058785 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MANTZOROS, CHRISTOS S · 2001 to 2011
$4.0M
The Role of Leptin in the Maintenance of a Reduced Body WeightR01DK079929 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MANTZOROS, CHRISTOS S · 2008 to 2012
$1.8M
Leptin and Adipokine PhysiologyK24DK081913 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MANTZOROS, CHRISTOS S · 2008 to 2020
$1.5M
Role of Leptin in the Neuroendocrine Response to FastingR56DK058785 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MANTZOROS, CHRISTOS S · 2005 to 2005
$85k
NIDDK NIH HHS DK-079929NIDDK NIH HHS DK-081913NIDDK NIH HHS DK-58785NIDDK NIH HHS K24 DK081913NIDDK NIH HHS R01 DK058785NIDDK NIH HHS R01 DK079929NIDDK NIH HHS R56 DK058785
6 · The paper itself

Abstract

Leptin, discovered through positional cloning 15 years ago, is an adipocyte-secreted hormone with pleiotropic effects in the physiology and pathophysiology of energy homeostasis, endocrinology, and metabolism. Studies in vitro and in animal models highlight the potential for leptin to regulate a number of physiological functions. Available evidence from human studies indicates that leptin has a mainly permissive role, with leptin administration being effective in states of leptin deficiency, less effective in states of leptin adequacy, and largely ineffective in states of leptin excess. Results from interventional studies in humans demonstrate that leptin administration in subjects with congenital complete leptin deficiency or subjects with partial leptin deficiency (subjects with lipoatrophy, congenital or related to HIV infection, and women with hypothalamic amenorrhea) reverses the energy homeostasis and neuroendocrine and metabolic abnormalities associated with these conditions. More specifically, in women with hypothalamic amenorrhea, leptin helps restore abnormalities in hypothalamic-pituitary-peripheral axes including the gonadal, thyroid, growth hormone, and to a lesser extent adrenal axes. Furthermore, leptin results in resumption of menses in the majority of these subjects and, in the long term, may increase bone mineral content and density, especially at the lumbar spine. In patients with congenital or HIV-related lipoatrophy, leptin treatment is also associated with improvements in insulin sensitivity and lipid profile, concomitant with reduced visceral and ectopic fat deposition. In contrast, leptin's effects are largely absent in the obese hyperleptinemic state, probably due to leptin resistance or tolerance. Hence, another emerging area of research pertains to the discovery and/or usefulness of leptin sensitizers. Results from ongoing studies are expected to further increase our understanding of the role of leptin and the potential clinical applications of leptin or its analogs in human therapeutics.

Indexed as

Adipose TissueAmenorrheaEnergy MetabolismFemaleHomeostasisHumansHypothalamic DiseasesHypothalamusLeptinMaleNeurosecretory SystemsReproductionLeptin

Identifiers

PMID21791620
PMCPMC3191548
OpenAlexW2010072332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.